IMPEDIMED TECHNOLOGY BACKED BY NEW STUDY

Written on the 14 September 2016 by James Perkins

IMPEDIMED TECHNOLOGY BACKED BY NEW STUDY A STUDY has found that Brisbane-based company ImpediMed's (ASX: IPD) L-Dex technology (pictured) is effective in monitoring patients that are at-risk of breast cancer related lymphoedema.

The study, conducted in the United States and published in the journal Frontiers in Oncology, reported that 326 patients were monitored with the L-Dex technology  post axillary lymph node dissection (ALND) or sentinel lymph node biopsy (SLNB).

Through monitoring fluid status and body composition through bioimpedance spectroscopy, L-Dex allowed for early intervention for patients who showed further incidence of sub-clinical lymphoedema after undergoing either an ALND or SLNB and allowed reduction in the persistence of this condition by 99.5 per cent for ALND patients and 91.4 per cent for SLNB patients.

The study concluded, "The results of this retrospective study demonstrate that L-Dex assessments can be incorporated into routine breast cancer programs as part of follow-up."

The researchers, from Texas, noted that this was critically important, given new health guidelines in the US for monitoring the post-treatment follow-up care of for breast cancer patients.

"As we await the results of the post-approval L-Dex study currently underway, we are pleased at the publication of these important and positive clinical data for L-Dex," says Richard Carreon, ImpediMed Managing Director and CEO in a statement to the ASX today.

L-Dex was developed by Associate Professor Leigh Ward from the University of Queensland.

IPD is trading up 6.55 per cent on the ASX this morning, at $3.94 per share.



Author: James Perkins Connect via: Twitter LinkedIn

Latest News

SA GOVERNMENT APPOINTS ESCAPENET TO DELIVER ULTRA HIGH-SPEED INTERNET

THE South Australian government has appointed Adelaide business EscapeNet to deliver a $7.6 million ultra high-spe...

CAIRNS COUPLE DIVE INTO THE SHARK TANK AND CONVINCE FELLOW 'BOATIE' GLEN RICHARDS TO WORK WITH THEM

THEY'RE a husband and wife team with an invention that can help save the Great Barrier Reef, and lives, and Pe...

AFTERPAY MERGER WITH TOUCHCORP GIVEN THE GO-AHEAD BY FEDERAL COURT

AFTERPAY Holdings Limited (ASX: AFY) has been given the green light by the Federal Court for its merger with Touch...

MEGAPORT TARGETS GLOBAL EXPANSION WITH $27.8M CAPITAL RAISING

MEGAPORT Limited (ASX: MP1) will complete a $27.8 million capital raising to assist in expanding the group's plat...

Related News

CAIRNS COUPLE DIVE INTO THE SHARK TANK AND CONVINCE FELLOW 'BOATIE' GLEN RICHARDS TO WORK WITH THEM

THEY'RE a husband and wife team with an invention that can help save the Great Barrier Reef, and lives, and Pe...

DOWNER EDI GRABS MORE THAN 50 PER CENT STAKE IN HOSTILE TAKEOVER TARGET SPOTLESS

DOWNER EDI Limited (ASX: DOW) now holds more than 50 per cent of Spotless Group Holdings Limited's (ASX: SPO) sha...

STRUGGLING TEN NETWORK IS 'CASH POSITIVE' AND CAN BE SAVED, ADMINISTRATOR SAYS

THE ADMINISTRATORS of the Ten Network say the struggling broadcaster has cash to continue operating and have also ind...

METCASH NET PROFIT FALLS 20 PER CENT, ANNOUNCES CEO WILL STEP DOWN IN 2018

FOOD and grocery giant Metcash has announced its full year net profit has fallen more than 20 per cent and its CEO Ia...

BOOK YOUR FUNCTION SPACE HERE

 

 

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter